600713 fundamentals
An in-depth look to NANJING PHARMACEUTICAL COMPANY LIMITED operating, investing, and financing activities
600713 free cash flow for Q3 24 is -649.53 M CNY. For 2023, 600713 free cash flow was 1.75 B CNY and operating cash flow was 1.91 B CNY.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM